Kuopion yliopistollinen sairaala
About Kuopion yliopistollinen sairaala
Kuopio University Hospital is a teaching hospital of the University of Eastern Finland along Puijonlaaksontie at the Puijonlaakso district in Kuopio, Finland.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
3
Hoffmann-La Roche
2
AM-Pharma
1
Inotrem
1
Pfizer
1
Clinical Trials at Kuopion yliopistollinen sairaala
During the past decade, Kuopion yliopistollinen sairaala conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on
average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular Edema
2011-01-01
2012-07-01
Completed
46
STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
2011-07-01
2017-06-14
Completed
1,232
A Safety, Tolerability, Efficacy and QoL Study of Human recAP in the Treatment of Patients With SA-AKI
2014-12-18
2017-09-27
Completed
301
Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic Shock
2019-11-13
2023-05-09
Active, not recruiting
355
This Study Collects Information on the Safety of Inhaled Pegylated Adrenomedullin (PEG-ADM), How the Drug is Tolerated and How it Affects Patients Suffering From a Type of Lung Failure That Cause Fluid to Build up in the Lungs Making Breathing Difficult (ARDS)
2020-07-07
2022-12-28
Terminated
90
Investigation of Radium-223 Dichloride (Xofigo), a Treatment That Gives Off Radiation That Helps Kill Cancer Cells, Compared to a Treatment That Inactivates Hormones (New Antihormonal Therapy, NAH) in Patients With Prostate Cancer That Has Spread to the Bone Getting Worse on or After Earlier NAH
2020-11-09
2025-05-01
Recruiting
696
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
2021-08-27
2033-11-21
Recruiting
4,100
A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke
2022-12-05
2025-08-25
Recruiting
18,000
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kuopion yliopistollinen sairaala" #1 sponsor was "Bayer" with 3 trials, followed by "Hoffmann-La Roche" with 2 trials
sponsored, "AM-Pharma" with 1 trials sponsored, "Inotrem" with 1 trials sponsored and "Pfizer"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kuopion yliopistollinen sairaala"
#1 collaborator was "PPD" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Kuopion yliopistollinen sairaala
According to Clinical.Site data, the most researched conditions in "Kuopion yliopistollinen sairaala" are
"Acute Kidney Injury" (1 trials), "Acute Respiratory Distress Syndrome" (1 trials), "Anti- VGF Inhibitor" (1 trials), "Atrial Fibrillation" (1 trials) and "Basal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Kuopion yliopistollinen sairaala" in a lesser frequency.
Clinical Trials Intervention Types at Kuopion yliopistollinen sairaala
Most popular intervention types in "Kuopion yliopistollinen sairaala" are "Drug" (7 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials), "Asundexian matching placebo" (1 trials) and "BAY1097761 Active Dose 1" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kuopion yliopistollinen sairaala
The vast majority of trials in "Kuopion yliopistollinen sairaala" are
7 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Kuopion yliopistollinen sairaala
Currently, there are NaN active trials in "Kuopion yliopistollinen sairaala".
undefined are not yet recruiting,
3 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Kuopion yliopistollinen sairaala,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Kuopion yliopistollinen sairaala, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".